ASPHALION HIGHLIGHTS Q3 2023
A lot of things have happened at Asphalion during these past three months, and we have summarized
October 20, 2023
A lot of things have happened at Asphalion during these past three months, and we have summarized
TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.
A lot of things have happened during these past three months. We received an award from AEFI
Test your Regulatory knowledge!! The summer is back and so is Asphalion’s #ASPHAQUIZ, our daily quiz to
Have a look at a recent success story of how Asphalion helped a local company expand its
During these two interactive days, leaders and world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and new trends. Discussion will focus on the actions, changes, evolutions and re-thinking needed to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to realise the improvements in both health and access.
This practical seminar is aimed at anyone
involved in planning, creating or submitting
variations.
The Advanced Therapies Congress is Europe´s largest cell and gene therapy conference and exhibition. The event is for the leaders of the world´s ATMPs developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward.
Search or filter
Services
Memberships & Partnerships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
